Unichem Laboratories is planning for capital expenditure in the current financial year, which includes the establishment of a new Special Economic Zone (SEZ) formulations plant and an R&D centre. In this regard, the company has set aside Rs 120 crore, of which Rs 40 crore would be spent for the formulations plant at the SEZ in Pithampur, and Rs 48 crore for an R&D centre and the balance for normal capex activities.
The new research and development (R&D) facility at Goa would come up in the vicinity of the existing plant. The company has purchased additional land at Goa adjacent to the existing plant to build new research centre and for future manufacturing expansions.
Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and APIs. The company offers products in therapeutic areas like gastro-intestinal, cardiovascular, diabetes, psychiatry, neurology, anti-bacterial, anti-infective and pain management, among others.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: